Submissions

1. General Principles and quality control:

General requirements:Manuscripts must be prepared in accordance with "Uniform requirements for Manuscripts submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors (Update October 2016) available at http://www.icmje.org/icmje-recommednations.pdf.

 Identification as author: The contributor of any article must fulfill the guidelines laid down by ICMJE (available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html) for being identified as author.

Peer review:The journal follows double blinded peer review. Average time period from submission of article to final decision is one to two months.

Blinding of manuscript:The journal usesdouble blinded peer reviewing processduring publication. Please ensure that the entire text of the manuscript except the title pageis blinded and doesn't contain any information that identifies the author/s or their affiliated institutions.

 Plagiarism:The journal utilizes plagiarism detection tools to identify the plagiarism. Any article with unacceptable levels of copied material will be rejected and authors may be barred from submitting articles to the journal in the future.

Retraction:Articles may be retracted post publication in an event of proven unethical behavior or if the article is found to be published elsewhere in any form.

2. Types of manuscripts and word limits

• Editorial: Editorial will be accepted for publication by invitation only.
• Original Article: Randomized controlled trials, interventional studies, studies of screening and diagnostic tests, outcome studies, cost effectiveness and analyses, case-control series and surveys: up to 2500 words excluding references (up to 30) and abstract (up to 250 words).
• Review Article: Systemic critical assessments of literature and data sources: Up to 3000 words excluding references (up to 50) and abstract (upto 250 words).
• Case Report: New/interesting/very rare cases with clinical significance or implications can be reported. Up to 1000 words excluding references (up to 10) and abstract (up to 100 words), up to three photographswould be accepted.
• Viewpoint: These articles are personal views and allow you to express your own point of view on any issues relevant to health. We would like these to include controversial subjects. Up to 800 words excluding references (up to 5-8) would be acceptable.
• Letter to the Editor: These should be short, decisive observations. They should not be preliminary observations that need a later paper for validation. Up to 400 words and 5 references would be acceptable.
• Limits for number of images and tables: on discretion of editors, as per guidelines.

3. Manuscript Preparation

 The entire manuscript including tables, charts and figures should be in a single Microsoft word document file. Use ‘Times New Roman’ font of size 11, black color and single-spaced for manuscript.

1. First page:

 Title Page should contain (only title page will contain the information that identifies the author and their institutions; rest of the manuscript should be blinded) the following parts in the order mentioned below:

1. Type of manuscript (e.g. Original article, Case Report)
2. The title of the article
3. Running title or short title not more than 50 characters
4. Name of authors, their email id, highest degree and their current affiliations.Also mention the contribution of each author in the study like conception, planning, intervention, data collection and interpretation, literature review, manuscript preparation and review etc.
5. The name, address, phone numberand e-mail address of the corresponding author.
6. Total word counts separately for abstract and for the text and number of charts and figures used.
7. Funding sources (mention as ‘none’ if no funding was received).
8. Acknowledgement: Contributors to the study who do not qualify for authorship.
9. Conflict of interest if any. (Mention as ‘none’ if there is no conflict of interest)
10. Abstract

The second page should carry the full title of the manuscript and an abstract. The abstract should be structured for original articles as: Introduction, Method, Result and Conclusion. Provide 3 to 8 keywords arranged alphabetically, separated by semicolon (;) and preferably not the words used in the title of the article.Do not include references in the abstract.

1. Introduction

Provide a context or background for the study (that is, the nature of the problem and its significance). State the specific purpose or research objective of, or hypothesis tested by, the study or observation; the research objective is often more sharply focused when stated as a question. General and specific objectives should be clear, and any pre-specified subgroup analyses should be described. Provide only directly pertinent references, and do not include data or conclusions from the work being reported.

1. Methods

The Methods section should only include information that was available at the time the study was planned or protocol written; all information obtained during the conduct of the study belongs to the results section. Type and method of consent or permission or approval taken before study should be mentioned in the methods section.

Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org/).

When reporting studies on human, indicate whether the procedures followed were in accordance with the ethical standards of Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/en/30publications/10policies/b3/index.html). Do not use patients' names, initials, or hospital numbers, especially in illustrative material.

Currently, our journal does not require approval from institutional or regional ethical committee for publication if ethical guidelines have been followed.However approval from the department or institution head for the research study conducted may be asked for when required. Hence it is recommended that the authors get the ethical clearance from their respective institutional ethical review committee beforehand.

1. Results 

Present your results in logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat data of tables or illustrations in the text; emphasize or summarize only the most important observations. Restrict tables and figures to those needed to explain the argument of the paper and to assess supporting data. Avoid nontechnical uses of technical terms in statistics, such as "random" (which implies a randomizing device), "normal," "significant," "correlations," and "sample." All units used should be in SI system. Do not mention the analysis, interpretations or comparisons of results with other studies in ‘Results’ section.

1. Discussion

Emphasize the new and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other information given in the Introduction or the Results section. For experimental studies, it is useful to begin the discussion by summarizing briefly the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and for clinical practice.

1. Conclusions

Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data. In particular, avoid making statements on economic benefits and costs unless the manuscript includes the appropriate economic data and analyses. Avoid claiming priority or alluding to work that has not been completed. State new hypotheses when warranted, but label them clearly as such.

1. References 

The responsibility of accuracy of the document cited as references will lie with the authors. Use Vancouver system of referencing with superscripted Arabic numbers without parenthesis for ‘in-text citation’ serially in the order of their appearances in the text. Authors should also ensure that digital object identifier id (DOI) of references are included with the references. To find the DOI of the reference cited please refer to the crossref resources available at http://apps.crossref.org/SimpleTextQuery.

If there are more than six authors for a particular reference replace all authors after sixth author as et al.

The style and punctuation of the references should conform to the following example: -

Journal

1. Zimmerman M, Shakya R, Pokhrel BM, Eyal N, Rijal BP, Shrestha RN, et al. Medical students' characteristics as predictors of career practice location: retrospective cohort study tracking graduates of Nepal's first medical college. BMJ 2012;345:e4826. DOI:1136/bmj.e4826.

              Book     

1. World Health Organization. Comprehensive cervical cancer control: A guide to essential practice. Second ed. Australia: WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland; 2014.DOI:https://doi.org/10.1097/00006250-198605000-00012For details of other types of references please refer to ICMJE Guidelines available at: (http://www.icmje.orgor http://www.nlm.nih.gov/bsd/uniform_requirements.html or http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/citmed/frontpage.html).
2. Tables and Figures

Tables and figures should be self explanatory and numbered in Arabic consecutively with caption. Explain all non-standard abbreviations in caption.Ensure that each table/figure is cited in the text in the sequentially in the order of their appearance. Excel files used to create chart and high-resolution pictures may be uploaded as supplementary files during submission process. Corresponding author may be asked for excel files or high-resolution pictures for the purpose of reconstruction of figures during typesetting process.

4. Submission process:

For submitting your article

• Go to journal webpage of JNPS available at https://jnps.org.np/jnps/ 
• Register with the journal as author. We recommend you register as reader, author and reviewer (https://jnps.org.np/jnps/index.php/jnps/register)
• Log in using your user ID and password (https://jnps.org.np/jnps/index.php/jnps/login)
• Submit your article by clicking on ‘new submission’ and following the self-explanatory 5-step process.
• Submitted article should be changed or modified using this same webpage after logging in.

 Copyright Transfer and Author Agreement 

• Copyright on any research article is transferred in full to the journal of Nepal Paediatric Society upon publication. The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).
• Articles in the journal of Nepal Paediatric Societyare Open Access articles published under the Creative Commons CC BY-NC-ND License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
• This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, is not changed in any way, and is not used for commercial purposes. 
• Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.